PVI
AZN icon

Pura Vida Investments’s AstraZeneca AZN Stock Holding History

Pura Vida Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50,000
Closed -$3.96M – 80
2018
Q3 		$3.96M Buy
+50,000
New +$3.78M 0.83% 36
2017
Q3 		– Sell
-100,000
Closed -$6.82M – 80
2017
Q2 		$6.82M Buy
+100,000
New +$6.53M 2.71% 11

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's AZN Position: Q4 2022 in Review

Pura Vida Investments sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 87,500 shares — an estimated $9.6M sold.

Pura Vida Investments first reported a position in AZN in Q3 2021 and held it in 4 quarters. The position peaked at $10.8M in Q2 2022. 1,062 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Pura Vida Investments reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 87,500 AstraZeneca shares in Q4 2022, an estimated $9.6M.
  • Pura Vida Investments first reported a position in AstraZeneca in Q3 2021 and held it in 4 quarters.
  • Pura Vida Investments's AstraZeneca position peaked at $10.8M in Q2 2022.
  • 1,062 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.